Selected research
Industry Research
Exosome Medical Technology Industry Research Report 2026
Market perspective
The global Exosome Medical Technology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Exosome Medical Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Exosome Medical Technology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Exosome Medical Technology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Exosome Medical Technology include Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Evox Therapeutics, Exosome Diagnostics, Inc., ExonanoRNA LLC.,, Codiak BioSciences and Esperite Group and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Exosome Medical Technology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Exosome Medical Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exosome Medical Technology Market by Company
Aegle Therapeutics
Anjarium Biosciences
Aruna Biomedical
Carmine Therapeutics
Evox Therapeutics
Exosome Diagnostics, Inc.
ExonanoRNA LLC.,
Codiak BioSciences
Esperite Group
Tavec Pharmaceuticals
Exosome Medical Technology Segment by Type
Transmission Electron Microscopy
Nanoparticle Tracking Analysis
Western Blot Molecular Marker Detection
Exosome Medical Technology Segment by Application
Healthcare Providers
Pharmaceutical & Biotechnology Companies
Others
Exosome Medical Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Medical Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Medical Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Medical Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Exosome Medical Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transmission Electron Microscopy
- Nanoparticle Tracking Analysis
- Western Blot Molecular Marker Detection
Applications
- Healthcare Providers
- Pharmaceutical & Biotechnology Companies
- Others
Companies covered
- Aegle Therapeutics
- Anjarium Biosciences
- Aruna Biomedical
- Carmine Therapeutics
- Evox Therapeutics
- Exosome Diagnostics, Inc.
- ExonanoRNA LLC.,
- Codiak BioSciences
- Esperite Group
- Tavec Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Exosome Medical Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Transmission Electron Microscopy
- 2.2.3 Nanoparticle Tracking Analysis
- 2.2.4 Western Blot Molecular Marker Detection
- 2.3 Exosome Medical Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Healthcare Providers
- 2.3.3 Pharmaceutical & Biotechnology Companies
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Exosome Medical Technology Breakdown Data by Type
- 3.1 Global Exosome Medical Technology Historic Market Size by Type (2021-2026)
- 3.2 Global Exosome Medical Technology Forecasted Market Size by Type (2027-2032)
4 Exosome Medical Technology Breakdown Data by Application
- 4.1 Global Exosome Medical Technology Historic Market Size by Application (2021-2026)
- 4.2 Global Exosome Medical Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Exosome Medical Technology Market Perspective (2021-2032)
- 5.2 Global Exosome Medical Technology Growth Trends by Region
- 5.2.1 Global Exosome Medical Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Exosome Medical Technology Historic Market Size by Region (2021-2026)
- 5.2.3 Exosome Medical Technology Forecasted Market Size by Region (2027-2032)
- 5.3 Exosome Medical Technology Market Dynamics
- 5.3.1 Exosome Medical Technology Industry Trends
- 5.3.2 Exosome Medical Technology Market Drivers
- 5.3.3 Exosome Medical Technology Market Challenges
- 5.3.4 Exosome Medical Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Exosome Medical Technology Players by Revenue
- 6.1.1 Global Top Exosome Medical Technology Players by Revenue (2021-2026)
- 6.1.2 Global Exosome Medical Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global Exosome Medical Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Exosome Medical Technology Head Office and Area Served
- 6.4 Global Exosome Medical Technology Players, Product Type & Application
- 6.5 Global Exosome Medical Technology Manufacturers Established Date
- 6.6 Global Exosome Medical Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Exosome Medical Technology Market Size (2021-2032)
- 7.2 North America Exosome Medical Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Exosome Medical Technology Market Size by Country (2021-2026)
- 7.4 North America Exosome Medical Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Exosome Medical Technology Market Size (2021-2032)
- 8.2 Europe Exosome Medical Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Exosome Medical Technology Market Size by Country (2021-2026)
- 8.4 Europe Exosome Medical Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Medical Technology Market Size (2021-2032)
- 9.2 Asia-Pacific Exosome Medical Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Exosome Medical Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Exosome Medical Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Exosome Medical Technology Market Size (2021-2032)
- 10.2 South America Exosome Medical Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Exosome Medical Technology Market Size by Country (2021-2026)
- 10.4 South America Exosome Medical Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Medical Technology Market Size (2021-2032)
- 11.2 Middle East & Africa Exosome Medical Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Exosome Medical Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Exosome Medical Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aegle Therapeutics
- 12.1.1 Aegle Therapeutics Company Information
- 12.1.2 Aegle Therapeutics Business Overview
- 12.1.3 Aegle Therapeutics Revenue in Exosome Medical Technology Business (2021-2026)
- 12.1.4 Aegle Therapeutics Exosome Medical Technology Product Portfolio
- 12.1.5 Aegle Therapeutics Recent Developments
- 12.2 Anjarium Biosciences
- 12.2.1 Anjarium Biosciences Company Information
- 12.2.2 Anjarium Biosciences Business Overview
- 12.2.3 Anjarium Biosciences Revenue in Exosome Medical Technology Business (2021-2026)
- 12.2.4 Anjarium Biosciences Exosome Medical Technology Product Portfolio
- 12.2.5 Anjarium Biosciences Recent Developments
- 12.3 Aruna Biomedical
- 12.3.1 Aruna Biomedical Company Information
- 12.3.2 Aruna Biomedical Business Overview
- 12.3.3 Aruna Biomedical Revenue in Exosome Medical Technology Business (2021-2026)
- 12.3.4 Aruna Biomedical Exosome Medical Technology Product Portfolio
- 12.3.5 Aruna Biomedical Recent Developments
- 12.4 Carmine Therapeutics
- 12.4.1 Carmine Therapeutics Company Information
- 12.4.2 Carmine Therapeutics Business Overview
- 12.4.3 Carmine Therapeutics Revenue in Exosome Medical Technology Business (2021-2026)
- 12.4.4 Carmine Therapeutics Exosome Medical Technology Product Portfolio
- 12.4.5 Carmine Therapeutics Recent Developments
- 12.5 Evox Therapeutics
- 12.5.1 Evox Therapeutics Company Information
- 12.5.2 Evox Therapeutics Business Overview
- 12.5.3 Evox Therapeutics Revenue in Exosome Medical Technology Business (2021-2026)
- 12.5.4 Evox Therapeutics Exosome Medical Technology Product Portfolio
- 12.5.5 Evox Therapeutics Recent Developments
- 12.6 Exosome Diagnostics, Inc.
- 12.6.1 Exosome Diagnostics, Inc. Company Information
- 12.6.2 Exosome Diagnostics, Inc. Business Overview
- 12.6.3 Exosome Diagnostics, Inc. Revenue in Exosome Medical Technology Business (2021-2026)
- 12.6.4 Exosome Diagnostics, Inc. Exosome Medical Technology Product Portfolio
- 12.6.5 Exosome Diagnostics, Inc. Recent Developments
- 12.7 ExonanoRNA LLC.,
- 12.7.1 ExonanoRNA LLC., Company Information
- 12.7.2 ExonanoRNA LLC., Business Overview
- 12.7.3 ExonanoRNA LLC., Revenue in Exosome Medical Technology Business (2021-2026)
- 12.7.4 ExonanoRNA LLC., Exosome Medical Technology Product Portfolio
- 12.7.5 ExonanoRNA LLC., Recent Developments
- 12.8 Codiak BioSciences
- 12.8.1 Codiak BioSciences Company Information
- 12.8.2 Codiak BioSciences Business Overview
- 12.8.3 Codiak BioSciences Revenue in Exosome Medical Technology Business (2021-2026)
- 12.8.4 Codiak BioSciences Exosome Medical Technology Product Portfolio
- 12.8.5 Codiak BioSciences Recent Developments
- 12.9 Esperite Group
- 12.9.1 Esperite Group Company Information
- 12.9.2 Esperite Group Business Overview
- 12.9.3 Esperite Group Revenue in Exosome Medical Technology Business (2021-2026)
- 12.9.4 Esperite Group Exosome Medical Technology Product Portfolio
- 12.9.5 Esperite Group Recent Developments
- 12.10 Tavec Pharmaceuticals
- 12.10.1 Tavec Pharmaceuticals Company Information
- 12.10.2 Tavec Pharmaceuticals Business Overview
- 12.10.3 Tavec Pharmaceuticals Revenue in Exosome Medical Technology Business (2021-2026)
- 12.10.4 Tavec Pharmaceuticals Exosome Medical Technology Product Portfolio
- 12.10.5 Tavec Pharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst